Josef Schoell, Chief Financial Officer at Cara Therapeutics, Inc. (CARA), sold 15,000 shares at $10.96 ($164K) on 2015-02-17, disclosed to the SEC on 2015-02-19.
Scheduled sale ($164k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.